目的 分析2019年郑州大学第一附属医院丹参川芎嗪注射液的临床使用情况，为促进中药注射剂的临床合理使用提供参考。方法 采用回顾性研究方法，利用PASS软件按5%比例抽取本院使用丹参川芎嗪注射液的出院病历755份，记录患者基本情况、药品使用情况等数据，进行Excel统计分析。结果 不合理使用例数为434例，占总例数的57.48%，其中无适应症占47.72%，用法用量不适宜占12.53%、用药疗程不当占11.43%、溶媒选择不当占6.91%及联合用药不合理占21.41%。结论 2019年本院丹参川芎嗪注射剂的临床使用存在不合理情况，应有针对性进行规范及整治，促进临床合理用药。

Objective To analyze the clinical application of Danshen Ligustrazine Injection in the First Affiliated Hospital of Zhengzhou University in 2019, so as to provide reference for promoting the rational clinical use of Chinese medicine injections. Methods With the retrospective study method, The data of 755 discharge medical records were selected by using PASS software at 5% in the First Affiliated Hospital of Zhengzhou University in 2019, and the basic information of patients and the use of drugs were recorded for Excel statistical analysis. Results The number of cases of unreasonable use was 434, accounting for 57.48% of the total cases. Among them, no indications accounted for 47.72%, while improper usage and dosage was 12.53%, improper course of medication accounted for 11.43%, improper solvent selection was 6.91%, and unreasonable combination of drugs accounted for 21.41%. Conclusion There are some unreasonable situations in the clinical use of Danshen Ligustrazine Injection in the First Affiliated Hospital of Zhengzhou University in 2019, which should be regulated and rectified pertinently to promote rational drug use.

R972